Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Deepak, Varade"'
Autor:
Gregg W. Stone, Michael E. Farkouh, Anuradha Lala, Elizabeth Tinuoye, Ovidiu Dressler, Pedro R. Moreno, Igor F. Palacios, Shaun G. Goodman, Rodrigo B. Esper, Alexandre Abizaid, Deepak Varade, Juan F. Betancur, Alejandro Ricalde, Gerardo Payro, José María Castellano, Ivan F.N. Hung, Girish N. Nadkarni, Gennaro Giustino, Lucas C. Godoy, Jason Feinman, Anton Camaj, Solomon W. Bienstock, Remo H.M. Furtado, Carlos Granada, Jessica Bustamante, Carlos Peyra, Johanna Contreras, Ruth Owen, Deepak L. Bhatt, Stuart J. Pocock, Valentin Fuster
Publikováno v:
Journal of the American College of Cardiology. 81:1747-1762
Autor:
Aashish, Mondal, Arindam, Naskar, Siddiqi, Sheelu Shafiq, Bhosle, Deepak, Mallikarjuna, V. J., Amol, Dange, Sanket, Sorate, Omkar, Gavali, Parth, Patel, Dhruvi, Hasnani, Durga, Prasad, Pradeep, Dalwadi, Suresh, Kumar, Vaishali, Pathak, Mayura, Chaudhari, Indraneel, Basu, Jayashri, Shembalkar, Arif, Fariooqui, Raghavendra, S. K., Deepak, Varade
Publikováno v:
Clinical Diabetes & Endocrinology; 2/10/2024, Vol. 10, p1-10, 10p
Autor:
Sishir, Gang, Prakash, Khetan, Deepak, Varade, Venkata Ramakrishna, Chinta, Siddharth, Mavani, Umesh, Gupta, S Venkata Krishna, Reddy, Sunil, Rajanna, Tarun, Jeloka, Vivek, Ruhela, Kevinkumar, Kansagra, Pooja, Kanani, Jayesh, Bhatt, Kuldipsinh, Zala
Publikováno v:
American journal of nephrology. 53(5)
A phase 3 study to assess the efficacy and safety of the desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, against the epoetin alfa for the treatment of anemia in patients with chronic kidney disease (CKD) with dialysis depen
Autor:
Dhananjai, Agrawal, Deepak, Varade, Hardik, Shah, Alm, Nazar, Jayakumar, Krishnan, Vineet, Shukla, Chinta, Ramakrishna, Mahel Chinthana, Bandara Galahitiyawa, Sidhharth B, Mavani, Sunil, Rajanna, Petkar, Jikki, Shamila, De Silva, Vivek, Ruhela, Parshottam, Koradia, Kevinkumar, Kansagra, Pooja, Kanani, Nitin, Sharma, Kuldipsinh, Zala, Deven, Parmar
Publikováno v:
American journal of nephrology. 53(5)
Desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is being developed to treat anemia in patients with chronic kidney disease (CKD) without dialysis dependency.In total, 588 patients with a clinical diagnosis of anemia due to